This is an addendum to the article available online at https://doi.org/10.1038/gim.2012.165.
Addendum to: Genetics in Medicine15:153–156 (2013); https://doi.org/10.1038/gim.2012.165, published online 3 October 2013.
This document was reaffirmed by the ACMG Board of Directors as of 27 April 2020 with the following addendum:
Since this document no longer meets the criteria for an evidence-based practice guideline by the College, it has been reclassified as a Clinical Practice Resource.
Article info
Publication history
Accepted:
May 13,
2020
Received:
May 13,
2020
In the original online version of this Article, the affiliation details for all of the authors were incorrectly given. They have now been corrected in HTML version of the Article.Identification
Copyright
© 2020, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics
User license
Elsevier user license | How you can reuse 
Elsevier's open access license policy
Elsevier user license
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testingGenetics in MedicineVol. 15Issue 2
- PreviewMTHFR polymorphism testing is frequently ordered by physicians as part of the clinical evaluation for thrombophilia. It was previously hypothesized that reduced enzyme activity of MTHFR led to mild hyperhomocysteinemia which led to an increased risk for venous thromboembolism, coronary heart disease, and recurrent pregnancy loss. Recent meta-analyses have disproven an association between hyperhomocysteinemia and risk for coronary heart disease and between MTHFR polymorphism status and risk for venous thromboembolism.
- Full-Text
- Preview
- Correction: Addendum: ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testingGenetics in MedicineVol. 22Issue 9Open Archive
